Group One Trading
ARCT icon

Group One Trading’s Arcturus Therapeutics ARCT Stock Holding History

Group One Trading’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.32K Sell
300
-800
-73% -$5.84K ﹤0.01% 7010
2025
Q4 		$6.74K Sell
1,100
-1,000
-48% -$10.8K ﹤0.01% 7041
2025
Q3 		$38.7K Sell
2,100
-51,900
-96% -$834K ﹤0.01% 6174
2025
Q2 		$703K Buy
54,000
+41,800
+343% +$494K ﹤0.01% 3091
2025
Q1 		$129K Buy
+12,200
New +$194K ﹤0.01% 4401
2024
Q4 		– Sell
-8,400
Closed -$195K – 7226
2024
Q3 		$195K Buy
8,400
+8,100
+2,700% +$173K ﹤0.01% 3632
2024
Q2 		$7.3K Sell
300
-2,600
-90% -$78.8K ﹤0.01% 5779
2024
Q1 		$97.9K Sell
2,900
-15,300
-84% -$542K ﹤0.01% 4181
2023
Q4 		$574K Buy
18,200
+9,200
+102% +$219K ﹤0.01% 2950
2023
Q3 		$230K Sell
9,000
-4,000
-31% -$123K ﹤0.01% 3683
2023
Q2 		$373K Buy
13,000
+7,900
+155% +$215K ﹤0.01% 3320
2023
Q1 		$122K Sell
5,100
-58,100
-92% -$1.04M ﹤0.01% 4124
2022
Q4 		$1.07M Buy
63,200
+10,200
+19% +$178K ﹤0.01% 2357
2022
Q3 		$785K Buy
53,000
+23,300
+78% +$391K ﹤0.01% 2805
2022
Q2 		$467K Sell
29,700
-53,500
-64% -$1.05M ﹤0.01% 3489
2022
Q1 		$2.24M Buy
83,200
+15,900
+24% +$406K ﹤0.01% 2286
2021
Q4 		$2.49M Buy
67,300
+30,000
+80% +$1.22M ﹤0.01% 2360
2021
Q3 		$1.78M Buy
37,300
+20,500
+122% +$919K ﹤0.01% 2785
2021
Q2 		$569K Sell
16,800
-19,100
-53% -$647K ﹤0.01% 4079
2021
Q1 		$1.48M Sell
35,900
-125,400
-78% -$7.47M ﹤0.01% 2781
2020
Q4 		$7M Buy
161,300
+116,500
+260% +$7.89M 0.01% 1048
2020
Q3 		$1.92M Sell
44,800
-29,900
-40% -$1.48M 0.01% 1625
2020
Q2 		$3.49M Buy
74,700
+29,300
+65% +$1.01M 0.02% 1053
2020
Q1 		$617K Buy
45,400
+39,400
+657% +$504K 0.01% 1896
2019
Q4 		$65K Buy
6,000
+2,400
+67% +$25.1K ﹤0.01% 3882
2019
Q3 		$37K Buy
3,600
+3,200
+800% +$34.6K ﹤0.01% 4115
2019
Q2 		$4K Hold
400
– – ﹤0.01% 4632
2019
Q1 		$3K Hold
400
– – ﹤0.01% 4511
2018
Q4 		$2K Sell
400
-3,600
-90% -$22.1K ﹤0.01% 4641
2018
Q3 		$35K Buy
4,000
+3,800
+1,900% +$31.6K ﹤0.01% 4154
2018
Q2 		$2K Buy
+200
New +$1.29K ﹤0.01% 4931
2018
Q1 		– Sell
-5,700
Closed -$45K – 4799
2017
Q4 		$45K Buy
5,700
+5,600
+5,600% +$50.4K ﹤0.01% 3779
2017
Q3 		$1K Sell
100
-686
-87% -$5.17K ﹤0.01% 4690
2017
Q2 		$6K Sell
786
-728
-48% -$5.86K ﹤0.01% 4355
2017
Q1 		$12K Sell
1,514
-10,957
-88% -$101K ﹤0.01% 4059
2016
Q4 		$183K Buy
12,471
+3,828
+44% +$57.2K ﹤0.01% 2483
2016
Q3 		$149K Buy
8,643
+4,657
+117% +$150K ﹤0.01% 2673
2016
Q2 		$125K Buy
3,986
+1,886
+90% +$59.4K ﹤0.01% 2703
2016
Q1 		$56K Sell
2,100
-1,500
-42% -$50.8K ﹤0.01% 3193
2015
Q4 		$158K Buy
3,600
+2,743
+320% +$123K ﹤0.01% 2668
2015
Q3 		$36K Sell
857
-4,200
-83% -$221K ﹤0.01% 3727
2015
Q2 		$232K Buy
5,057
+3,514
+228% +$161K ﹤0.01% 2420
2015
Q1 		$61K Buy
1,543
+472
+44% +$20.8K ﹤0.01% 3245
2014
Q4 		$28K Sell
1,071
-47,929
-98% -$1.52M ﹤0.01% 3762
2014
Q3 		$5.3M Buy
49,000
+40,671
+488% +$5.3M 0.08% 276
2014
Q2 		$1.01M Buy
+8,329
New +$1.01M 0.02% 1133

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's ARCT Position: Q4 2025 in Review

Group One Trading sold out of Arcturus Therapeutics (ARCT) in Q4 2025, closing a stake of 44,427 shares — an estimated $480K sold.

Group One Trading first reported a position in ARCT in Q4 2014 and held it in 36 quarters. The position peaked at $1.47M in Q4 2015. 120 funds tracked by Wall St. Rank hold ARCT as of Q4 2025.

  • Group One Trading reported no remaining Arcturus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 44,427 Arcturus Therapeutics shares in Q4 2025, an estimated $480K.
  • Group One Trading first reported a position in Arcturus Therapeutics in Q4 2014 and held it in 36 quarters.
  • Group One Trading's Arcturus Therapeutics position peaked at $1.47M in Q4 2015.
  • 120 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.